Bioadvise ApS: Financial statements 2020
CVR: 39920034
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Bioadvise ApS (CVR 39920034) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 447,895 and a net result of DKK 90,794 compared with DKK 76,894 the year before. That is an increase of 18.9% compared with the year before. Equity in the 2020 report amounted to DKK 288,532. The solvency ratio was 65.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 447,895
- Profit/Loss
- DKK 90,794
- Equity
- DKK 288,532
- Total Assets
- DKK 438,325
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 448 t. | 91 t. | 289 t. | 1 |
| 2019 | - | 377 t. | 77 t. | 198 t. | 1 |
Official annual report
How creditworthy is Bioadvise ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Bioadvise ApS has published its annual report for 2019. Gross profit came to DKK 376,671, and the net result was DKK 76,894.
About Bioadvise ApS
Bioadvise ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2018. The company has been dissolved on 21 September 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Bioadvise IVS. The company has 1 employee (2020). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -210,600 the year before. Equity in the 2025 report amounted to DKK -34,634.